secwatch.observer — SEC 8-K summary ====================================== Issuer: Orthofix Medical Inc. (OFIX) CIK: 0000884624 Form: 8-K Filed at: 2024-01-08T23:59:59+00:00 Accession: 0000950170-24-002924 Event type: leadership Sentiment: neutral Materiality: 0.65 Item codes: 7.01, 9.01 LLM model: deepseek-v4-flash:cloud@v2 Massimo Calafiore begins as Orthofix CEO immediately; Julie Andrews named CFO effective Jan 15 -------------------------------------------------------------------------------- - Massimo Calafiore assumes role of President and CEO effective immediately and joins the Board of Directors. - Julie Andrews appointed CFO effective January 15, 2024; previously CFO at Smart Wires Technology and SVP Finance at Wright Medical. - Catherine Burzik, who served as interim CEO, steps down from that role but remains Chair of the Board. - Appointments fill key leadership roles following a search that attracted many highly qualified candidates. Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/884624/000095017024002924/0000950170-24-002924-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/884624/000095017024002924/ofix-20240108.htm HTML page: https://secwatch.observer/filing/0000950170-24-002924 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer